Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Hua Medicine
2552Current price
1.67 HKD
-0.06 HKD (-3.47%)
Last closed
1.71 HKD
Company
www.huamedicine.com
ISIN
KYG4644K1022
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Hong Kong Stock Exchange
Capitalization
1 767 720 285 HKD
Yield for 12 month
-3.47 %
1Y
3Y
5Y
10Y
15Y
2552
Hua Medicine (Shanghai) Ltd. operates as a drug development company that focuses on therapies for the treatment of diabetes in China. It develops Dorzagliatin or HMS5552, an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin for treatment of T2D and DKD. The company also offers Dorzagliatin in combination with GLP1RA for T2D and obesity; in combination with insulin to treat Type 1 Diabetes; second generation glucokinase (GK) inhibitor for metabolic disease; mGLUR5 negative allosteric modulator (NAM) for PD-LID and drug addiction; and GK NAM for metabolic disease. The company was incorporated in 2011 and is based in Shanghai, China. Address: Building 2, Lane 36, Shanghai, China, 201203
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
27.94 HKDP/E ratio
–Dividend Yield
–Current Year
+82 681 994 HKD
Last Year
+18 993 875 HKD
Current Quarter
–
Last Quarter
–
Current Year
+40 336 212 HKD
Last Year
+8 298 415 HKD
Current Quarter
–
Last Quarter
–
Key Figures 2552
1 year
3 years
5 years
10 years
EBITDA
-383 309 384 HKD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-17.81 %
PEG Ratio
–
Return On Equity TTM
-300.57 %
Wall Street Target Price
27.94 HKD
Revenue TTM
109 046 802 HKD
Book Value
-0.034 HKD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
46 %
Dividend Yield
–
Gross Profit TTM
7 696 397 HKD
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
–
Profit Margin
-241.76 %
Dividend Analytics 2552
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 2552
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 2552
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
5.1766
Price Sales TTM
16.2107
Enterprise Value EBITDA
-11.5504
Price Book MRQ
10.5004
Financials 2552
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 2552
For 52 weeks
1.03 HKD
2.65 HKD
50 Day MA
1.39 HKD
Shares Short Prior Month
–
200 Day MA
1.49 HKD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart